Search Results - "Chamorro, Diego F"

Temporally Generalizable Land Cover Classification: A Recurrent Convolutional Neural Network Unveils Major Coastal Change through Time by Gray, Patrick Clifton, Chamorro, Diego F., Ridge, Justin T., Kerner, Hannah Rae, Ury, Emily A., Johnston, David W.

“…The ability to accurately classify land cover in periods before appropriate training and validation data exist is a critical step towards understanding subtle…”
Get full text

Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question by Ordóñez-Reyes, Camila, Garcia-Robledo, Juan Esteban, Chamorro, Diego F., Mosquera, Andrés, Sussmann, Liliana, Ruiz-Patiño, Alejandro, Arrieta, Oscar, Zatarain-Barrón, Lucia, Rojas, Leonardo, Russo, Alessandro, de Miguel-Perez, Diego, Rolfo, Christian, Cardona, Andrés F.

“…Immunotherapy has redefined the treatment of cancer patients and it is constantly generating new advances and approaches. Among the multiple options of…”
Get full text

Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP) by Raez, Luis E., Arrieta, Oscar, Chamorro, Diego F., Soberanis-Piña, Pamela Denisse, Corrales, Luis, Martín, Claudio, Cuello, Mauricio, Samtani, Suraj, Recondo, Gonzalo, Mas, Luis, Zatarain-Barrón, Zyanya Lucia, Ruíz-Patiño, Alejandro, García-Robledo, Juan Esteban, Ordoñez-Reyes, Camila, Jaller, Elvira, Dickson, Franco, Rojas, Leonardo, Rolfo, Christian, Rosell, Rafael, Cardona, Andrés F.

“…ObjectivesTo compare the rate disparity between outcomes (overall survival (OS), progression-free survival (PFS), and safety) of concurrent chemoradiation…”
Get full text

Integration of artificial intelligence and precision oncology in Latin America by Sussman, Liliana, Garcia-Robledo, Juan Esteban, Ordóñez-Reyes, Camila, Forero, Yency, Mosquera, Andrés F., Ruíz-Patiño, Alejandro, Chamorro, Diego F., Cardona, Andrés F.

“…Next-generation medicine encompasses different concepts related to healthcare models and technological developments. In Latin America and the Caribbean,…”
Get full text

Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors by Sotelo-Rodríguez, Carolina, Vallejo-Ardila, Dora, Ruiz-Patiño, Alejandro, Chamorro, Diego F, Rodríguez, July, Moreno-Pérez, Darwin A, Carranza, Hernán, Otero, Jorge, Vargas, Carlos, Archila, Pilar, Rojas, Leonardo, Zuluaga, Jairo, Rubio, Cladelis, Ordóñez-Reyes, Camila, Garcia-Robledo, Juan Esteban, Mejía, Sergio, Jaller, Elvira, Arrieta, Oscar, Cardona, Andrés F

“…Multidisciplinary molecular tumor boards (MTBs) decode complex genomic data into clinical recommendations. Although MTBs are well-established in the oncology…”
Get full text

Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential by Chamorro, Diego F, Somes, Lauren K, Hoyos, Valentina

“…Breast cancer remains a significant health challenge, and novel treatment approaches are critically needed. This review presents an in-depth analysis of…”
Get full text

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study by Chamorro, Diego F., Cardona, Andrés F., Rodríguez, July, Ruiz-Patiño, Alejandro, Arrieta, Oscar, Moreno-Pérez, Darwin A., Rojas, Leonardo, Zatarain-Barrón, Zyanya Lucia, Ardila, Dora V., Viola, Lucia, Recondo, Gonzalo, Blaquier, Juan B., Martín, Claudio, Raez, Luis, Samtani, Suraj, Ordóñez-Reyes, Camila, Garcia-Robledo, Juan Esteban, Corrales, Luis, Sotelo, Carolina, Ricaurte, Luisa, Cuello, Mauricio, Mejía, Sergio, Jaller, Elvira, Vargas, Carlos, Carranza, Hernán, Otero, Jorge, Archila, Pilar, Bermudez, Maritza, Gamez, Tatiana, Russo, Alessandro, Malapelle, Umberto, de Miguel Perez, Diego, de Lima, Vladmir C. Cordeiro, Freitas, Helano, Saldahna, Erick, Rolfo, Christian, Rosell, Rafael

“…Background Epidermal growth factor receptor ( EGFR) mutations ( EGFR m) represent one of the most common genomic alterations identified among patients with…”
Get full text

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP) by Cardona, Andrés F., Ruiz-Patiño, Alejandro, Recondo, Gonzalo, Martín, Claudio, Raez, Luis, Samtani, Suraj, Minatta, José Nicolas, Blaquier, Juan Bautista, Enrico, Diego, Burotto, Mauricio, Ordóñez-Reyes, Camila, Chamorro, Diego F., Garcia-Robledo, Juan Esteban, Corrales, Luis, Zatarain-Barrón, Zyanya Lucia, Más, Luis, Sotelo, Carolina, Ricaurte, Luisa, Santoyo, Nicolas, Cuello, Mauricio, Mejía, Sergio, Jaller, Elvira, Vargas, Carlos, Carranza, Hernán, Otero, Jorge, Rodríguez, July, Archila, Pilar, Bermudez, Maritza, Gamez, Tatiana, Cordeiro de Lima, Vladmir, Freitas, Helano, Russo, Alessandro, Polo, Carolina, Malapelle, Umberto, Perez, Diego de Miguel, Rolfo, Christian, Viola, Lucia, Rosell, Rafael, Arrieta, Oscar

“…•Our study is the first real-world analysis of Osimertinib in the first line setting in Hispanic patients and post-progression results.•Osimertinib is an…”
Get full text

STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) by Cordeiro de Lima, Vladmir C., Corassa, Marcelo, Saldanha, Erick, Freitas, Helano, Arrieta, Oscar, Raez, Luis, Samtani, Suraj, Ramos, Maritza, Rojas, Carlos, Burotto, Mauricio, Chamorro, Diego F., Recondo, Gonzalo, Ruiz-Patiño, Alejandro, Más, Luis, Zatarain-Barrón, Lucia, Mejía, Sergio, Nicolas Minata, José, Martín, Claudio, Bautista Blaquier, Juan, Motta Guerrero, Rodrigo, Aliaga-Macha, Carlos, Carracedo, Carlos, Ordóñez- Reyes, Camila, Garcia-Robledo, Juan Esteban, Corrales, Luis, Sotelo, Carolina, Ricaurte, Luisa, Santoyo, Nicolas, Cuello, Mauricio, Jaller, Elvira, Rodríguez, July, Archila, Pilar, Bermudez, Maritza, Gamez, Tatiana, Russo, Alessandro, Viola, Lucia, Malapelle, Umberto, de Miguel Perez, Diego, Rolfo, Christian, Rosell, Rafael, Cardona, Andrés F.

“…•STK11 and KEAP1 have been described as poor prognostic factors in patients treated with immune checkpoint inhibitors (ICIs).•This is the larger study to…”
Get full text

Perspectiva oncológica de la medicina de precisión y su implementación en pacientes pediátricos y adultos con genes de fusión NTRK: una visión para Colombia by Vargas, Carlos, Sotelo, Carolina, Chamorro, Diego F., Pino, Luis Eduardo, Archila, Pilar, Sua, Luz Fernanda, Sarmiento, Isabel, Rodríguez, July, Ruíz Patiño, Alejandro, Rojas, Leonardo, Carranza, Hernán, Otero, Jorge, Ricaurte, Luisa, García-Robledo, Juan Esteban, Ordóñez-Reyes, Camila, Corrales, Luis, Martín, Claudio, Raez, Luis, Rolfo, Christian, Arrieta, Oscar, Zatarain-Barrón, Lucía, Mosquera-Paternina, Andrés Felipe, Forero Martínez, Yency Johana, Cardona, Andrés F.

“…La oncología de precisión, definida como la perfilación molecular de los tumores para identificar alteraciones modulables, se ha desarrollado rápidamente para…”
Get full text